News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

SurModics (SRDX) To Webcast Third Quarter 2017 Earnings Conference Call On August 3



7/25/2017 7:39:28 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs

Webcast is Live at 7:30 a.m. (CT)

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that it will host a live webcast of its third quarter fiscal 2017 conference call on Thursday, August 3, at 7:30 a.m. CT (8:30 a.m. ET). The Company will issue an earnings news release earlier that morning.

Gary Maharaj, president and chief executive officer, and Andy LaFrence, vice president of finance and information systems and chief financial officer, will recap the third quarter 2017 financial results and accomplishments. To access the webcast, go to the investor relations portion of the Company’s website at www.surmodics.com the day of the conference call and click on the webcast icon.

An audio replay will be available beginning at 10:30 a.m. CT on Thursday, August 3, until 10:30 a.m. CT on Thursday, August 10, and can be accessed by dialing 888-203-1112 and entering conference call ID passcode 3371788. In addition, the conference call audio and transcript will be archived on the Company’s website following the call.

About Surmodics, Inc.

Surmodics is the global leader in surface modification technologies for intravascular medical devices and a leading provider of chemical components for in vitro diagnostic (IVD) tests and microarrays. Following two recent acquisitions of Creagh Medical and NorMedix, the Company is executing a key growth strategy for its medical device business by expanding to offer total intravascular product solutions to its medical device customers. The combination of proprietary surface technologies, along with enhanced device design, development and manufacturing capabilities, enables Surmodics to significantly increase the value it offers with highly differentiated intravascular solutions designed and engineered to meet the most demanding requirements. With this focus on offering total product solutions, Surmodics’ mission remains to improve the detection and treatment of disease by using its technology to provide solutions to difficult medical device and diagnostic challenges. Surmodics is headquartered in Eden Prairie, Minnesota. For more information about the company, visit www.surmodics.com. The content of Surmodics’ website is not part of this press release or part of any filings that the company makes with the SEC.

Contacts

Surmodics, Inc.
Andy LaFrence, 952-500-7000
ir@surmodics.com


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES